Smart (dis)investment choices in healthcare

Past event

Health
starts
ends
Read the report
Health

Summary

A greying Europe needs to take advantage of new technology and to empower patients in order to make healthcare more effective and less costly, panellists told a Friends of Europe Policy Insight on 7 November 2018.

They were speaking at the launch of a report, Smart (Dis)Investment Choices In Healthcare, that resulted from a series of working groups and other contributions ahead of next year’s European elections. It focusses in particular on smarter investment for better health and disinvestment from health interventions that are ineffective, inefficient and outdated. The report came up with recommendations for innovation that is citizen-centred, data-fuelled and outcome-focussed.

“We are at a tipping point. The scale of cheaper technology is huge,” said Loubna Bouarfa, Chief Executive Officer and Founder of OKRA Technologies, an artificial intelligence data analytics company for healthcare. “We only see an increase in health services consumption and at the same time in computer storage. We need to use that storage to allow for this huge consumption.” She called on the European Commission to develop means to make it easier for entrepreneurs to scale up solutions based on data. “In America you can scale, but in Europe we are regulated. That is great for citizens but a barrier for innovation.”

Europe has a good record in innovation, but not in the large-scale, commercial application of those advances. “Are we looking at one common goal: if I have an innovation, how can European patients enjoy it faster?” asked Andrea Rappagliosi, Vice President, Market Access and Public Affairs & Communication EMEA, Canada and LATAM at Edwards Lifesciences. “We obviously need security, safety and norms. The issue is how we can move from a risk-adverse culture to a really pro-innovation culture where new technology is adopted faster.” He added that healthcare facilities built in the 50s are not fit for purpose for implementing the latest technology-based treatments.

The report put forward five recommendations for the future of healthcare in Europe: empowerment of citizens, through health literacy efforts; an outcome-based approach to health; a health-data zone to better understand healthcare needs; making innovation the norm in health to maximise the opportunity of digitalisation; and redesigning health so that it has a model fit for purpose in the 21st century.

“At the centre is empowering citizens,” said Dharmendra Kanani, Director of insights at Friends of Europe, who presented the report’s outcomes. “People can buy pharmaceuticals on Amazon and diagnose themselves via the Internet. To make this work in this century, we are going to have to make sure that patients are empowered to do the right things and are involved centrally in solutions-making and problem-solving. Patients have to cease being seen as passive recipients and instead become a dominant feature and seen as an asset in how we solve problems and create systems.”

Though it is up to national governments to organise and provide healthcare, the European Commission complements national policies by helping governments achieve shared objectives, generating economies of scale and helping EU countries tackle shared challenges such as pandemics, chronic diseases and the impact of increased life expectancy.

“People realise that a strong transformation of our healthcare systems is needed, and they are ready for that,” said Sylvain Giraud, Head of Unit for Performance of National Health Systems in the European Commission Directorate-General for Health and Food Safety. “It is clearly sometimes about spending more. But in many cases, it is about spending better. Reducing waste is one of the most important elements in the transformations and reforms in all the EU member states. It is not only about the sustainability of public finances but also about effectiveness, accessibility and resilience.”

Smart (dis)investment choices in healthcare

About

About

In 2018, Friends of Europe launched a working group series on health (dis)investment, gathering various key stakeholders from the healthcare sector and beyond, to discuss how a systematic approach to spending in health can earmark both funds for innovation and release resources for practices that don’t deliver better health results.

This debate will launch the report of the health (dis)investment series, presenting the outcomes of these discussions which brings together the views of a large network of health professionals, policymakers, scholars and business representatives on health investments. Key recommendations will be presented and discussed amongst participants, ahead of the new European Commission and Parliament to be elected in 2019.

Related content:

Schedule

Schedule

Welcome & registration
Smart (dis)investment choices in healthcare Expand Smart (dis)investment choices in healthcare

Healthcare systems across the OECD countries are being challenged by ageing populations, increasing costs and limited funds. On top of that, not all money invested in health is well spent and not all interventions are fit for purpose. Addressing this issue would release much needed resources and improve health outcomes. Progress has been made at EU level in finetuning approaches to evaluating new technologies (HTA) and overall health system performance (HSPA). These are building blocks in a smart investment strategy. But few countries have developed strategies to actively disinvest in redundant, outdated or ineffective treatments. Research is missing on how to identify which health interventions are of minor or no health benefit.

  • What role does the EU play in ensuring that all stakeholders in healthcare can be rewarded for better health outcomes?
  • What could be the key elements in a possible common EU approach to health disinvestment?
  • What can the EU do to generate the evidence needed for smart investment decision-making for health at national, regional or local level?
  • Big data and AI are expected to revolutionise healthcare, but there are concerns around ethics and privacy of patient data. Beyond the GDPR, what can the EU do to support the revolution?

Speakers

Loubna Bouarfa

Chief Executive Officer and Founder of OKRA Technologies, an artificial intelligence data analytics company for healthcare

Wolfgang Burtscher

Deputy Director-General, DG RTD, European Commission

Sylvain Giraud

Head of Unit for Performance of National Health Systems, European Commission Directorate-General for Health and Food Safety

Andrea Rappagliosi

Vice-President, Market Access and Public Affairs, EMEA, Canada and LATAM, at Edwards Lifesciences

Khalil Rouhana

European Commission Deputy Director-General for Communications Networks, Content and Technology

Moderated

Dharmendra Kanani

Director of Insights at Friends of Europe

Speakers

Speakers

Loubna Bouarfa
Loubna Bouarfa

Chief Executive Officer and Founder of OKRA Technologies, an artificial intelligence data analytics company for healthcare

Show more information on Loubna Bouarfa

Loubna Bouarfa is a machine learning scientist turned entrepreneur. After several years in academia she, an engineer by training with a specific focus on applying AI for healthcare, founded OKRA Technologies, a health data analysis platform, using Artificial Intelligence to equip healthcare and life sciences professionals with the foresight to improve patient outcomes. Bouarfa has also recently been appointed by the European Commission as a High-Level Expert on Artificial Intelligence, supporting the EU by developing recommendations on ethical, legal and societal issues related to AI, impacting the health of the wider society. Bouarfa was awarded the title of Leading Innovator by the MIT Technology Review in 2017 and features amongst Forbes’ list of Top Women in Tech 2018.

Wolfgang Burtscher
Wolfgang Burtscher

Deputy Director-General, DG RTD, European Commission

Show more information on Wolfgang Burtscher

With more than 18 years’ experience in the European Commission, Wolfgang Burtscher was appointed Deputy Director-General in October 2009, focusing on “Open Innovation and Open Science, Open to the World”. Prior to joining the Directorate General (DG) for Research and Innovation, he acted as a Director in DG Agriculture. Throughout his career, Burtscher was representative of the Länder at the Austrian Permanent Representation to the EU and director of European Affairs in the Vorarlberg administration. Previously he was a legal advisor at the European Free Trade Association (EFTA) at the time of negotiations on the European Economic Area (EEA). 

Sylvain Giraud
Sylvain Giraud

Head of Unit for Performance of National Health Systems, European Commission Directorate-General for Health and Food Safety

Show more information on Sylvain Giraud

With over 15 years’ experience at the European Commission, Sylvain Giraud is one of the Directorate-General for Health and Food Safety’s top experts on the performance of national health systems across Europe. He is notably in charge of developing country-specific and cross-country knowledge of health systems and supporting cooperation across the EU. Prior to his current position, Giraud worked on international health issues and policy coordination in the same Directorate-General and on institutional cooperation in the European Commission’s Secretariat-General. Giraud started his career by working for European trade associations and consultancies in Brussels.

Photo of Dharmendra Kanani
Dharmendra Kanani

Director of Insights at Friends of Europe

Show more information on Dharmendra Kanani

Dharmendra Kanani has been in senior leadership roles in the Public and Voluntary sectors across the UK and Europe over a period of 26 years. In 2005, he was appointed as Director of Scotland of the Big Lottery Fund. Subsequently, from 2010 to 2014, Kanani was the England Director at the Big Lottery Fund, the largest independent funder in the UK. Since 2016, he has supported Friends of Europe’s strategic development across all its policy areas with a strong focus on Climate and Energy; Peace, Security and Defence as well as Digitalisation. Prior to this role, Kanani was the European Foundation Centre’s (EFC) first Fellow in July 2014. 

Andrea Rappagliosi
Andrea Rappagliosi

Vice-President, Market Access and Public Affairs, EMEA, Canada and LATAM, at Edwards Lifesciences

Show more information on Andrea Rappagliosi

An acknowledged business leader in the health sector, Andrea Rappagliosi has held numerous senior positions within leading pharmaceutical companies, including Baxter, Merck, GlaxoSmithKline and Sanofi. He now serves as Vice-President of Edwards Lifesciences, the global leader in the science of heart valves and hemodynamic monitoring. In recent years, Andrea represented the healthcare industry in several European EU Commission and Member States initiatives, such as the EU HTA Network Commission, the EU Active & Healthy Aging Innovation Partnership and was member of the European Commission High Level Pharmaceutical Forum (Relative Effectiveness and Pricing).

Photo of Khalil Rouhana
Khalil Rouhana

European Commission Deputy Director-General for Communications Networks, Content and Technology

Show more information on Khalil Rouhana

A research engineer by training, Khalil Rouhana has over 25 years of experience within the European Commission. As Deputy Director-General, Rouhana’s responsibilities include policies for the digital economy, notably for research, innovation and industrial strategies, digital solution for societal challenges as well as cybersecurity. Prior to joining the Commission, Rouhana started his career as a research and development engineer for the aeronautics industry and deputy director for the electrical engineering division of the French University in Beirut. Rouhana also served as the director of Esigetel, (Ecole supérieure d’Ingénieurs en Génie Informatique et Télécommunications”), a renowned French school of engineering. 

Partners

Continue
the debate on

Insights

view all insights

Next Event

view all events

Author

Track title

Category

00:0000:00
Stop playback
Video title

Category

Close

We use cookies to improve your online experience.
For more information, visit our privacy policy